288 related articles for article (PubMed ID: 25432807)
1. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Richardus JH; Oskam L
Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
[TBL] [Abstract][Full Text] [Related]
2. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
[TBL] [Abstract][Full Text] [Related]
4. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
[TBL] [Abstract][Full Text] [Related]
5. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
6. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
Schuring RP; Richardus JH; Pahan D; Oskam L
Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
[TBL] [Abstract][Full Text] [Related]
9. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
Smith WC; Aerts A
Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
[TBL] [Abstract][Full Text] [Related]
10. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study.
Fischer EA; de Vlas SJ; Habbema JD; Richardus JH
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1330. PubMed ID: 21949895
[TBL] [Abstract][Full Text] [Related]
11. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
Janaszek W
Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
14. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP.
Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH
Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
Ferreira SMB; Yonekura T; Ignotti E; Oliveira LB; Takahashi J; Soares CB
JBI Database System Rev Implement Rep; 2017 Oct; 15(10):2555-2584. PubMed ID: 29035966
[TBL] [Abstract][Full Text] [Related]
16. South India immunoprophylaxis trial against leprosy: relevance of findings in the context of leprosy trends.
Gupte MD
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S10-3. PubMed ID: 11757173
[No Abstract] [Full Text] [Related]
17. SIMLEP: a simulation model for leprosy transmission and control.
Meima A; Gupte MD; van Oortmarssen GJ; Habbema JD
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):215-36. PubMed ID: 10575401
[TBL] [Abstract][Full Text] [Related]
18. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?
Richardus JH; Habbema JD
Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706
[TBL] [Abstract][Full Text] [Related]
19. Prevention of transmission of leprosy: The current scenario.
Palit A; Kar HK
Indian J Dermatol Venereol Leprol; 2020; 86(2):115-123. PubMed ID: 31975697
[TBL] [Abstract][Full Text] [Related]
20. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
